Large Decrease Seen in Antidepressant Use During Pregnancy
MONDAY, Feb. 3, 2025 -- There has been a large decrease in antidepressant use during pregnancy and no corresponding increase in psychotherapy claims, according to a research letter published online Jan. 30 in JAMA Network Open.
Claire Boone, Ph.D., from McGill University in Montreal, and colleagues measured antidepressant medication fills and psychotherapy claims of women and their spouses for two years before and two years after the birth of a child (2009 to 2019). The study included 385,731 women.
The researchers found that 4.3 and 2.2 percent of women filled an antidepressant prescription in the year before pregnancy and during pregnancy, respectively, a reduction of 48.8 percent. No similar change was seen in antidepressant use among 217,877 spouses, indicating that this behavior was not associated with co-occurring changes in the couple's life. During pregnancy, there was a slight decrease in psychotherapy claims related to a trend line. Women's mean medication fills returned to the prepregnancy trend line within one month of giving birth.
"We documented a large decrease in antidepressant use without an accompanying increase in psychotherapy during pregnancy," the authors write. "These findings, coupled with evidence of mental health challenges during and after pregnancy, suggest the need for increased focus on and discussion about mental health treatments by pregnant women and their clinicians."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Read this next
Poor Mental Health Outcomes More Likely With Hyperemesis Gravidarum
FRIDAY, Sept. 26, 2025 -- Hyperemesis gravidarum is associated with an increased risk for poorer mental health outcomes compared with pregnancy without hyperemesis gravidarum...
Young Adult Cancer Survivors Face Higher Social Risks
FRIDAY, Sept. 26, 2025 -- Young adult cancer survivors face elevated social risks, according to a study presented at the 18th AACR Conference on the Science of Cancer Health...
Psilocybin-Assisted Therapy Aids Symptoms of Major Depressive Disorder
THURSDAY, Sept. 25, 2025 -- Psilocybin-assisted therapy (PAT) shows long-term safety and efficacy for treating symptoms of major depressive disorder (MDD), according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.